{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:00:36Z","timestamp":1766901636431,"version":"3.48.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10721-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:51:07Z","timestamp":1751374267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic silencing of the tumor suppressor TIMP-3 gene in upstream CpG islands in thyroid neoplasms: a cross-sectional study with systematic review"],"prefix":"10.1007","volume":"52","author":[{"given":"Maryam","family":"Zarkesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noman","family":"Arab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raziyeh","family":"Abooshahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabnam","family":"Heydarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Nozhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marziyeh Salehi","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Ahmad","family":"Fanaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"4","key":"10721_CR1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C et al (2022) The epidemiological landscape of thyroid cancer worldwide: globocan estimates for incidence and mortality rates in 2020. Lancet Diabet Endocrinol 10(4):264\u2013272","journal-title":"Lancet Diabet Endocrinol"},{"issue":"1","key":"10721_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK et al (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33(1):27\u201363","journal-title":"Endocr Pathol"},{"key":"10721_CR3","unstructured":"Lloyd R, Osamura R, Rosai J. 2022 WHO Classification of tumours editorial board: endocrine and neuroendocrine tumours. International agency for research on cancer. Lyon, France"},{"key":"10721_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijscr.2020.06.070","volume":"73","author":"A Abdelaal","year":"2020","unstructured":"Abdelaal A, El Ansari W, Abusabeib A, Farghaly H, Tabeb AAM (2020) Simultaneous occurrence of follicular and papillary thyroid carcinomas in same thyroid lobe: a case series of six patients from Qatar. Int J Surg Case Rep 73:65\u201370","journal-title":"Int J Surg Case Rep"},{"issue":"10","key":"10721_CR5","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25(10):1010\u20131022","journal-title":"Genes Dev"},{"issue":"3","key":"10721_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2217\/epi.15.114","volume":"8","author":"S Moran","year":"2016","unstructured":"Moran S, Arribas C, Esteller M (2016) Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics 8(3):389\u2013399","journal-title":"Epigenomics"},{"issue":"12","key":"10721_CR7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/15592294.2019.1638701","volume":"14","author":"M Ehrlich","year":"2019","unstructured":"Ehrlich M (2019) DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics 14(12):1141\u20131163","journal-title":"Epigenetics"},{"key":"10721_CR8","doi-asserted-by":"crossref","first-page":"153303382412503","DOI":"10.1177\/15330338241250317","volume":"23","author":"F Akram","year":"2024","unstructured":"Akram F, Tanveer R, Andleeb S, Shah FI, Ahmad T, Shehzadi S et al (2024) Deciphering the epigenetic symphony of cancer: insights and epigenetic therapies implications. Technol Cancer Res Treat 23:15330338241250316","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"10721_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/CBM-190871","volume":"28","author":"IV Iancu","year":"2020","unstructured":"Iancu IV, Botezatu A, Plesa A, Huica I, Fudulu A, Albulescu A et al (2020) Alterations of regulatory factors and DNA methylation pattern in thyroid cancer. Cancer Biomark 28(2):255\u2013268","journal-title":"Cancer Biomark"},{"issue":"1","key":"10721_CR10","first-page":"8","volume":"4","author":"R Sun","year":"2022","unstructured":"Sun R, Zhu P (2022) Advances in measuring DNA methylation. Blood Sci (Baltimore, Md) 4(1):8\u201315","journal-title":"Blood Sci (Baltimore, Md)"},{"issue":"1","key":"10721_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40291-017-0303-y","volume":"22","author":"M Zarkesh","year":"2018","unstructured":"Zarkesh M, Zadeh-Vakili A, Azizi F, Foroughi F, Akhavan MM, Hedayati M (2018) Altered epigenetic mechanisms in thyroid cancer subtypes. Mol Diagn Ther 22(1):41\u201356","journal-title":"Mol Diagn Ther"},{"issue":"12","key":"10721_CR12","first-page":"2461","volume":"50","author":"S Sheikkholeslami","year":"2021","unstructured":"Sheikkholeslami S, Zarif-Yeganeh M, Farashi S, Azizi F, Kia SK, Teimoori-Toolabi L et al (2021) Promoter methylation of tumor suppressors in thyroid carcinoma: a systematic review. Iran J Public Health 50(12):2461\u20132472","journal-title":"Iran J Public Health"},{"key":"10721_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.archoralbio.2018.12.001","volume":"98","author":"JK Strzelczyk","year":"2019","unstructured":"Strzelczyk JK, Krakowczyk \u0141, Owczarek AJ (2019) Methylation status of SFRP1, SFRP2, RASSF1A, RAR\u03b2 and DAPK1 genes in patients with oral squamous cell carcinoma. Arch Oral Biol 98:265\u2013272","journal-title":"Arch Oral Biol"},{"issue":"9","key":"10721_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184892","volume":"12","author":"F Khatami","year":"2017","unstructured":"Khatami F, Larijani B, Heshmat R, Keshtkar A, Mohammadamoli M, Teimoori-Toolabi L et al (2017) Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer. PLoS ONE 12(9):e0184892","journal-title":"PLoS ONE"},{"issue":"7","key":"10721_CR15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/labinvest.2009.50","volume":"89","author":"T Kondo","year":"2009","unstructured":"Kondo T, Nakazawa T, Ma D, Niu D, Mochizuki K, Kawasaki T, Nakamura N, Yamane T, Kobayashi M, Katoh R (2009) Epigenetic silencing of TTF-1\/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas. Lab Investig 89(7):791\u2013799","journal-title":"Lab Investig"},{"key":"10721_CR16","doi-asserted-by":"crossref","first-page":"794490","DOI":"10.3389\/fendo.2021.794490","volume":"12","author":"S Cai","year":"2021","unstructured":"Cai S, Ma J, Wang Y, Cai Y, Xie L, Chen X et al (2021) Biomarker value of miR-221 and miR-222 as potential substrates in the differential diagnosis of papillary thyroid cancer based on data synthesis and bioinformatics approach. Front Endocrinol 12:794490","journal-title":"Front Endocrinol"},{"issue":"17","key":"10721_CR17","doi-asserted-by":"crossref","first-page":"28028","DOI":"10.18632\/oncotarget.15885","volume":"8","author":"W Ma","year":"2017","unstructured":"Ma W, Zhao X, Liang L, Wang G, Li Y, Miao X et al (2017) miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4. Oncotarget 8(17):28028\u201328041","journal-title":"Oncotarget"},{"issue":"3","key":"10721_CR18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/art.22427","volume":"56","author":"S Sahebjam","year":"2007","unstructured":"Sahebjam S, Khokha R, Mort JS (2007) Increased collagen and aggrecan degradation with age in the joints of Timp3\u2212\/\u2212 mice. Arthritis Rheum 56(3):905\u2013909","journal-title":"Arthritis Rheum"},{"issue":"24","key":"10721_CR19","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acu\u00f1a JM, Perez-Romero BA, Guerrero-Rodriguez JF et al (2020) The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci 21(24):9739","journal-title":"Int J Mol Sci"},{"issue":"27","key":"10721_CR20","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1038\/onc.2011.18","volume":"30","author":"M Anania","year":"2011","unstructured":"Anania M, Sensi M, Radaelli E, Miranda C, Vizioli M, Pagliardini S et al (2011) TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells. Oncogene 30(27):3011\u20133023","journal-title":"Oncogene"},{"issue":"2","key":"10721_CR21","doi-asserted-by":"crossref","first-page":"e56120-e","DOI":"10.5812\/ijem.56120","volume":"16","author":"M Zarkesh","year":"2018","unstructured":"Zarkesh M, Zadeh-Vakili A, Azizi F, Fanaei SA, Foroughi F, Hedayati M (2018) The association of BRAF V600E mutation with tissue inhibitor of metalloproteinase-3 expression and clinicopathological features in papillary thyroid cancer. Int J Endocrinol Metab 16(2):e56120-e","journal-title":"Int J Endocrinol Metab"},{"issue":"8","key":"10721_CR22","doi-asserted-by":"crossref","first-page":"e106161","DOI":"10.1371\/journal.pone.0106161","volume":"9","author":"X Gu","year":"2014","unstructured":"Gu X, Fu M, Ding Y, Ni H, Zhang W, Zhu Y et al (2014) TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC. PLoS ONE 9(8):e106161","journal-title":"PLoS ONE"},{"key":"10721_CR23","first-page":"175883591986424","volume":"11","author":"CW Su","year":"2019","unstructured":"Su CW, Lin CW, Yang WE, Yang SF (2019) TIMP-3 as a therapeutic target for cancer. Therapeutic Adv Med Oncol 11:1758835919864247","journal-title":"Therapeutic Adv Med Oncol"},{"issue":"4","key":"10721_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm846","volume":"9","author":"JH Qi","year":"2003","unstructured":"Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M et al (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9(4):407\u2013415","journal-title":"Nat Med"},{"issue":"7","key":"10721_CR25","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1210\/jc.2005-0313","volume":"90","author":"MO Hoque","year":"2005","unstructured":"Hoque MO, Rosenbaum E, Westra WH, Xing M, Ladenson P, Zeiger MA et al (2005) Quantitative assessment of promoter methylation profiles in thyroid neoplasms. J Clin Endocrinol Metab 90(7):4011\u20134018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10721_CR26","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/ijc.22110","volume":"119","author":"S Hu","year":"2006","unstructured":"Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, Cohen Y et al (2006) Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer 119(10):2322\u20132329","journal-title":"Int J Cancer"},{"issue":"7","key":"10721_CR27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/epi.20524","volume":"7","author":"M Brait","year":"2012","unstructured":"Brait M, Loyo M, Rosenbaum E, Ostrow KL, Markova A, Papagerakis S et al (2012) Correlation between BRAF mutation and promoter methylation of TIMP3, RAR\u03b22 and RASSF1A in thyroid cancer. Epigenetics 7(7):710\u2013719","journal-title":"Epigenetics"},{"issue":"2","key":"10721_CR28","first-page":"1","volume":"4","author":"JK Stephen","year":"2015","unstructured":"Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ (2015) Methylation markers for early detection and differentiation of follicular thyroid cancer subtypes. Cancer Clin Oncol 4(2):1","journal-title":"Cancer Clin Oncol"},{"issue":"2","key":"10721_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40618-017-0702-2","volume":"41","author":"JK Stephen","year":"2018","unstructured":"Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ (2018) Methylation markers differentiate thyroid cancer from benign nodules. J Endocrinol Invest 41(2):163\u2013170","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10721_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/biom13020318","volume":"13","author":"MJ Abraham","year":"2023","unstructured":"Abraham MJ, El Sherbini A, El-Diasty M, Askari S, Szewczuk MR (2023) Restoring epigenetic reprogramming with diet and exercise to improve health-related metabolic diseases. Biomolecules 13(2):318","journal-title":"Biomolecules"},{"issue":"6","key":"10721_CR31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/thy.2017.0102","volume":"27","author":"RM Tuttle","year":"2017","unstructured":"Tuttle RM, Haugen B, Perrier ND (2017) Updated American joint committee on cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (Eighth Edition): what changed and why? Thyroid Off J Am Thyroid Assoc 27(6):751\u2013756","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"1","key":"10721_CR32","first-page":"198582","volume":"2014","author":"R Weber","year":"2014","unstructured":"Weber R, Bertoni APS, Bessestil LW, Brasil BMDAA, Brum LS, Furlanetto TW (2014) Validation of reference genes for normalization gene expression in reverse transcription quantitative PCR in human normal thyroid and goiter tissue. BioMed Res Int 2014(1):198582","journal-title":"BioMed Res Int"},{"issue":"15","key":"10721_CR33","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.3390\/ijerph18157975","volume":"18","author":"Y Piao","year":"2021","unstructured":"Piao Y, Xu W, Park KH, Ryu KH, Xiang R (2021) Comprehensive evaluation of differential methylation analysis methods for bisulfite sequencing data. Int J Environ Res Public Health 18(15):7975","journal-title":"Int J Environ Res Public Health"},{"key":"10721_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-61779-316-5_2","volume":"791","author":"Y Li","year":"2011","unstructured":"Li Y, Tollefsbol TO (2011) DNA methylation detection: bisulfite genomic sequencing analysis. Methods Mol Biol (Clifton, NJ) 791:11\u201321","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"key":"10721_CR35","doi-asserted-by":"crossref","unstructured":"Jiang M, Zhang Y, Fei J, Chang X, Fan W, Qian X, Zhang T, Lu D (2010) Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces. Lab investig 90(2):282\u2013290","DOI":"10.1038\/labinvest.2009.132"},{"issue":"1","key":"10721_CR36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12859-016-1347-4","volume":"17","author":"L Weinhold","year":"2016","unstructured":"Weinhold L, Wahl S, Pechlivanis S, Hoffmann P, Schmid M (2016) A statistical model for the analysis of beta values in DNA methylation studies. BMC Bioinform 17(1):480","journal-title":"BMC Bioinform"},{"issue":"4","key":"10721_CR37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"10721_CR38","doi-asserted-by":"crossref","first-page":"756458","DOI":"10.3389\/fcell.2021.756458","volume":"9","author":"D Das","year":"2021","unstructured":"Das D, Karthik N, Taneja R (2021) Crosstalk between inflammatory signaling and methylation in cancer. Front Cell Develop Biol 9:756458","journal-title":"Front Cell Develop Biol"},{"issue":"1","key":"10721_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44155-023-00039-z","volume":"3","author":"MHM Chan","year":"2023","unstructured":"Chan MHM, Merrill SM, Konwar C, Kobor MS (2023) An integrative framework and recommendations for the study of DNA methylation in the context of race and ethnicity. Discov Soc Sci Health 3(1):9","journal-title":"Discov Soc Sci Health"},{"issue":"3","key":"10721_CR40","first-page":"338","volume":"44","author":"B Xu","year":"2018","unstructured":"Xu B, Ghossein R (2018) Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management. Eur J Surg Oncol J Eur Soc Surg Oncol British Assoc Surg Oncol 44(3):338\u2013347","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol British Assoc Surg Oncol"},{"issue":"1","key":"10721_CR41","doi-asserted-by":"crossref","first-page":"12067","DOI":"10.1038\/s41598-020-69008-9","volume":"10","author":"AP Carreca","year":"2020","unstructured":"Carreca AP, Pravat\u00e0 VM, Markham M, Bonelli S, Murphy G, Nagase H et al (2020) TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1. Sci Rep 10(1):12067","journal-title":"Sci Rep"},{"key":"10721_CR42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2019.03.033","volume":"164","author":"S Zhong","year":"2019","unstructured":"Zhong S, Khalil RA (2019) A disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease. Biochem Pharmacol 164:188\u2013204","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10721_CR43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.31557\/apjcb.2023.8.1.75-89","volume":"8","author":"A Pathak","year":"2023","unstructured":"Pathak A, Tomar S, Pathak S (2023) Epigenetics and cancer: a comprehensive review. Asian Pacific J Cancer Biol 8(1):75\u201389","journal-title":"Asian Pacific J Cancer Biol"},{"issue":"1","key":"10721_CR44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews HK, Bertoli C, de Bruin RA (2022) Cell cycle control in cancer. Nat Rev Mol Cell Biol 23(1):74\u201388","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10721_CR45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mc.22121","volume":"54","author":"G Deb","year":"2015","unstructured":"Deb G, Thakur VS, Limaye AM, Gupta S (2015) Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Mol Carcinog 54(6):485\u2013499","journal-title":"Mol Carcinog"},{"issue":"11","key":"10721_CR46","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/tox.23333","volume":"36","author":"K Serala","year":"2021","unstructured":"Serala K, Steenkamp P, Mampuru L, Prince S, Poopedi K, Mbazima V (2021) In vitro antimetastatic activity of Momordica balsamina crude acetone extract in HT-29 human colon cancer cells. Environ Toxicol 36(11):2196\u20132205","journal-title":"Environ Toxicol"},{"issue":"6","key":"10721_CR47","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.3390\/ijms25063191","volume":"25","author":"W-T Lee","year":"2024","unstructured":"Lee W-T, Wu P-Y, Cheng Y-M, Huang Y-F (2024) Tissue inhibitor of metalloproteinase 3: unravelling its biological function and significance in oncology. Int J Mol Sci 25(6):3191","journal-title":"Int J Mol Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10721-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:24:28Z","timestamp":1766895868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10721-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10721"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10721-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was received approval from the Ethics Committee of the Research Institute of Endocrine Sciences at Shahid Beheshti University of Medical Sciences (IR.SBMU.ENDOCRINE.REC.1402.10). All procedures were conducted in accordance with the Declaration of Helsinki and the institutional guidelines of RIES. Written informed consent was obtained each participant prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was received approval from the Ethics Committee of the Research Institute of Endocrine Sciences at Shahid Beheshti University of Medical Sciences (IR.SBMU.ENDOCRINE.REC.1402.10). All procedures were conducted in accordance with the Declaration of Helsinki and the institutional guidelines of RIES. Written informed consent was obtained each participant prior to enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have reviewed and approved the final version of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"665"}}